Adaptive Biotechnologies Corp
(ADPT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,458 | 0 | N/A | 0 | 0 |
| Marketable Securities | 374,543 | 0 | N/A | 0 | 0 |
| Receivables | 7,252 | 0 | N/A | 0 | 0 |
| Inventories | 8,004 | 0 | N/A | 0 | 0 |
| TOTAL | $442,301 | $0 | $N/A | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 22,298 | N/A | N/A | N/A | N/A |
| Intangibles | 131,756 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,040 | 0 | 0 | 0 | 0 |
| TOTAL | $159,094 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $601,395 | $0 | $N/A | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,944 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 9,448 | 0 | N/A | 0 | 0 |
| TOTAL | $74,862 | $0 | $N/A | $0 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 62,470 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,602 | 0 | 0 | 0 | 0 |
| TOTAL | $248,976 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $323,838 | $0 | $N/A | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 124,288 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | N/A | 0 | 0 |
| Retained earnings | -330,917 | 0 | N/A | 0 | 0 |
| Other shareholders' equity | 562,313 | 0 | 0 | 0 | 0 |
| TOTAL | $277,557 | $0 | $N/A | $0 | $0 |
| Total Liabilities And Equity | $601,395 | $0 | $0 | $0 | $0 |